>
Iran rejects Trump's terms of deal to lift Hormuz blockade
Cheap Debt Today, Pain Tomorrow
Watch LIVE: Hegseth Prepares US Troops For Ground Invasion As Trump To Announce...
Spencer Pratt reveals plan to make Hollywood great again amid Tinseltown exodus as bombshell...
Elon and SpaceX Have Made AI Training 10 Times Faster
Oklo COO Says Nuclear Waste Could Power America For 150 Years
SpaceX Announces LARGEST Starship Mission Ever! They've never done this before!
Cars Are Fast Becoming Dystopian Prison Pods...
Our Emergency Water Plan Wasn't Good Enough - So We Built This
Sodium Ion Batteries Can Reach 100 Gigawatt Per Hour Per Year Scale in 2027
Juiced Bikes proves capable electric motorcycles don't have to cost a lot
Headlight projectors turn your car into a drive-in theater
US To Develop Small Modular Nuclear Reactors For Commercial Shipping
New York Mandates Kill Switch and Surveillance Software in Your 3D Printer ...

Scientists at University College London (UCL) have demonstrated in rodents a new type of "micromagnet" that can work as a miniaturized mechanical switch to turn on touch-sensitive cells, offering a new method for controlling specific regions of the brain.
There are parallels between this breakthrough and another exciting branch of research focused on careful control of cells in the body, known as optogenetics. This technique involves inserting genes into otherwise regular calls to make them sensitive to light, allowing them to be stimulated for the purposes of treating paralysis, relieving pain and restoring vision.
Although there have been success stories, such as a case when optogenetics was used for partial vision restoration in a human for the first time last year, adapting the technology for clinical use has proven difficult due to the need for genetic modification of the cells. The UCL team has come up with another way of controlling brain activity that doesn't involve such measures.
"Our new technology uses magnetic particles and magnets to remotely and precisely control brain cell activity and, importantly, does this without introducing any device or foreign gene into the brain," said lead researcher Dr Yichao Yu.
The team's magnet-centric approach involves targeting brain cells called astrocytes, which live between the brain's blood vessels and nerve cells and supply neurons with metabolic and structural support, while also regulating activity of neuronal circuits. Conveniently for the scientists, they also happen to be touch-sensitive.
"Because astrocytes are sensitive to touch, decorating them with magnetic particles means you can give the cells a tiny prod from outside the body using a magnet, and as such, control their function," said senior author, Professor Mark Lythgoe. "This ability to remotely control astrocytes provides a new tool for understanding their function and may have the potential to treat brain and mood disorders, including depression."